- Home
- CCIR vs BNTC Comparison
CCIR vs BNTC Comparison
Compare CCIR & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCIR
- BNTC
- Stock Information
- Founded
- CCIR 2021
- BNTC 1995
- Country
- CCIR United States
- BNTC United States
- Employees
- CCIR N/A
- BNTC N/A
- Industry
- CCIR
- BNTC Biotechnology: Pharmaceutical Preparations
- Sector
- CCIR
- BNTC Health Care
- Exchange
- CCIR NYSE
- BNTC Nasdaq
- Market Cap
- CCIR 349.1M
- BNTC 366.6M
- IPO Year
- CCIR 2024
- BNTC N/A
- Fundamental
- Price
- CCIR $11.08
- BNTC $14.97
- Analyst Decision
- CCIR
- BNTC Strong Buy
- Analyst Count
- CCIR 0
- BNTC 6
- Target Price
- CCIR N/A
- BNTC $23.83
- AVG Volume (30 Days)
- CCIR 441.5K
- BNTC 89.4K
- Earning Date
- CCIR 01-01-0001
- BNTC 05-14-2025
- Dividend Yield
- CCIR N/A
- BNTC N/A
- EPS Growth
- CCIR N/A
- BNTC N/A
- EPS
- CCIR 0.12
- BNTC N/A
- Revenue
- CCIR N/A
- BNTC N/A
- Revenue This Year
- CCIR N/A
- BNTC N/A
- Revenue Next Year
- CCIR N/A
- BNTC N/A
- P/E Ratio
- CCIR $87.40
- BNTC N/A
- Revenue Growth
- CCIR N/A
- BNTC N/A
- 52 Week Low
- CCIR $9.92
- BNTC $6.66
- 52 Week High
- CCIR $13.35
- BNTC $17.15
- Technical
- Relative Strength Index (RSI)
- CCIR N/A
- BNTC 49.28
- Support Level
- CCIR N/A
- BNTC $13.60
- Resistance Level
- CCIR N/A
- BNTC $17.10
- Average True Range (ATR)
- CCIR 0.00
- BNTC 1.21
- MACD
- CCIR 0.00
- BNTC -0.21
- Stochastic Oscillator
- CCIR 0.00
- BNTC 38.59
About CCIR COHEN CIRCLE ACQUISITION CORP I
Cohen Circle Acquisition Corp I is a blank check company.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.